Back to Search
Start Over
Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease
- Source :
- Journal of neurochemistryReferences. 152(5)
- Publication Year :
- 2019
-
Abstract
- One of the major hallmarks of Alzheimer's disease (AD) pathology is the formation of extracellular amyloid β (Aβ) plaques. While Aβ has been suggested to be critical in inducing and, potentially, driving the disease, the molecular basis of AD pathogenesis is still under debate. Extracellular Aβ plaque pathology manifests itself upon aggregation of distinct Aβ peptides, resulting in morphologically different plaque morphotypes, including mainly diffuse and cored senile plaques. As plaque pathology precipitates long before any clinical symptoms occur, targeting the Aβ aggregation processes provides a promising target for early interventions. However, the chain of events of when, where and what Aβ species aggregate and form plaques remains unclear. The aim of this study was to investigate the potential of matrix-assisted laser desorption/ionization imaging mass spectrometry as a tool to study the evolving pathology in transgenic mouse models for AD. To that end, we used an emerging, chemical imaging modality - matrix-assisted laser desorption/ionization imaging mass spectrometry - that allows for delineating Aβ aggregation with specificity at the single plaque level. We identified that plaque formation occurs first in cortical regions and that these younger plaques contain higher levels of 42 amino acid-long Aβ (Aβ1-42). Plaque maturation was found to be characterized by a relative increase in deposition of Aβ1-40, which was associated with the appearance of a cored morphology for those plaques. Finally, other C-terminally truncated Aβ species (Aβ1-38 and Aβ1-39) exhibited a similar aggregation pattern as Aβ1-40, suggesting that these species have similar aggregation characteristics. These results suggest that initial plaque formation is seeded by Aβ1-42; a process that is followed by plaque maturation upon deposition of Aβ1-40 as well as deposition of other C-terminally modified Aβ species.
- Subjects :
- 0301 basic medicine
MALDI imaging
Genetically modified mouse
Male
Pathology
medicine.medical_specialty
Mice, Transgenic
Plaque, Amyloid
Disease
Biochemistry
Protein Aggregation, Pathological
Mass spectrometry imaging
Pathogenesis
03 medical and health sciences
Cellular and Molecular Neuroscience
Mice
0302 clinical medicine
Alzheimer Disease
Extracellular
medicine
Animals
Senile plaques
Amyloid beta-Peptides
Chemistry
Aβ peptide
Brain
Mice, Inbred C57BL
Disease Models, Animal
030104 developmental biology
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 14714159
- Volume :
- 152
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Journal of neurochemistryReferences
- Accession number :
- edsair.doi.dedup.....9aa0e4ce8b8b3048aa3899e0ff94b04c